ESHG 2025
24 - 27 May 2025 CEST
Milan, Italy

Oxford Nanopore at ESHG 2025

Oxford Nanopore will be at Booth 400 in the exhibit hall at the European Society for Human Genetics Annual Meeting in April, 2025, hosted in Milan, IT. We will also host a Corporate Session on Monday, 26th May, 2025. Details and registration below.

Register for Oxford Nanopore activities at ESHG 2025
milan

Corporate Session

Shaping the landscape of rare disease research in Europe

Location: Amber 7+8

Date: Monday, 26th May

Time: 12:00 - 13:00 CEST

Identifying the molecular cause of rare diseases is critical for enabling improved patient management, guiding treatment options, and providing clarity on prognosis. However, despite the adoption of short-read sequencing in routine diagnostic workflows, more than half of individuals living with a rare disease remain without a genetic answer. One reason is that short-read methods can overlook complex genomic features such as structural variants, repeat expansions, and other large-scale rearrangements. Additionally, methylation studies often require separate assays, adding complexity and time to an already challenging process.

Emerging clinical research now demonstrates that comprehensive long-read sequencing can address these limitations by offering higher resolution and a broader range of variant detection than short-read sequencing — potentially increasing diagnostic yield. Oxford Nanopore Technologies provides a powerful platform for capturing all these challenging variants and base modifications in a single dataset. By integrating multiple layers of genomic information, Oxford Nanopore Technologies supports a streamlined approach from sample preparation to variant interpretation.

In this session, Prof. Olaf Reiss will introduce the European Long Read Innovation Network (ELRIN) consortium, an initiative dedicated to driving the adoption of cutting-edge genomic testing. Their goal is to ensure that advanced tools are readily accessible and practical for potential clinical use across diverse settings. Dr Erika Souche will follow with new data highlighting how the comprehensive data generated by Oxford Nanopore sequencing can enhance the detection of complex genomic variation. Join us for this workshop to explore the advantages of Oxford Nanopore sequencing for clinical research and discover how more families affected by rare diseases can gain meaningful insights into their conditions.

Agenda

Agenda

12:00 – 13:00 hrs CEST

Agenda (subject to change)

12:00 - 12:10 hrs

Welcome

Magali Kemoun, Oxford Nanopore Technologies

12:10 - 12:30 hrs

ELRIN - A European diagnostic long read Sequencing network

Olaf Rieß, University of Tübingen

12:30 - 12:50 hrs

Assessing the clinical utility of Oxford Nanopore sequencing

Erika Souche, KU Leuven

12:50 - 13:00 hrs

Q&A and closing remarks

Magali Kemoun, Oxford Nanopore Technologies

Speakers

Welcome & Closing

Magali Kemoun, VP Sales, EMEAI, Oxford Nanopore Technologies

...

picture of Olaf Rieß

ELRIN - A European diagnostic long read Sequencing network

Olaf Rieß, Professor, University of Tübingen

Prof. Riess, MD, is full professor for Medical Genetics and Director of the Institute of Medical Gen...

picture of Erika Souche

Assessing the clinical utility of Oxford Nanopore sequencing

Erika Souche, Research Scientist & Bioinformatician, KU Leuven

Erika Souche is a research scientist and bioinformatician in the laboratory for Cytogenetics and Gen...

On-booth activities

Booth 400

Saturday, 24th May

Sunday, 25th May

Monday, 26th May

10:15 hrs — Resolving complex haplotypes in PGx genes

Hayley Greenfield, Oxford Nanopore Technologies

10:15 hrs — A tour of the dark genome

Heather Jeffery, Oxford Nanopore Technologies

10:15 am — Enhanced assembly insights with Oxford Nanopore sequencing

Heather Jeffery, Oxford Nanopore Technologies

12:30 hrs — EPI2ME updates: Oxford Nanopore Technologies' comprehensive analysis platform

Sirisha Hesketh, Oxford Nanopore Technologies

12:15 hrs — Resolving complex haplotypes in PGx genes

Hayley Greenfield, Oxford Nanopore Technologies

12:15 pm — EPI2ME updates: Oxford Nanopore Technologies' comprehensive analysis platform

Sirisha Hesketh Oxford Nanopore Technologies

16:15 hrs — Enhanced assembly insights with Oxford Nanopore sequencing

Heather Jeffery, Oxford Nanopore Technologies

15:15 hrs – Clinical and research applications of long-read sequencing

Danny Miller, Universty of Washington

15:45 hrs — Resolving complex haplotypes in PGx genes

Hayley Greenfield, Oxford Nanopore Technologies

15:30 hrs - 16:30 hrs – Booth drinks reception

Clinical and research applications of long-read sequencing

Prof. Danny Miller, University of Washington, will present on the Oxford Nanopore booth between 15:30 – 16:30 hrs on Sunday 25th May.

In this talk, Prof. Miller will discuss clinical and research uses of long-read sequencing, including the development of control databases, and provide examples of clinically relevant variants missed by prior testing.

v2danny-miller-color

Demo descriptions

Resolving complex haplotypes in PGx genes

In this workflow, we demonstrate a targeted pharmacogenomics approach that combines the Twist Alliance Long-Read PGx Panel with Oxford Nanopore sequencing. This method enables high-throughput, long-read analysis of up to 48 multiplexed samples per PromethION flow cell. The approach provides accurate resolution of complex haplotypes in PGx genes from patient-derived cell lines, supporting comprehensive pharmacogenomic profiling.

EPI2ME updates: Oxford Nanopore Technologies' comprehensive analysis platform

This demo will provide an update on EPI2ME, ONT's comprehensive platform offering an intuitive interface for running analysis workflows both locally and in the cloud. We'll highlight recent developments, new features, and show how EPI2ME streamlines human genomic analysis.​

Enhanced assembly insights with Oxford Nanopore sequencing

This presentation will provide n insight into the different assembly outputs that can be achieved with different sequencing kits.

A tour of the dark genome

In this talk, we will discuss a range of challenging medically relevant genes, including some with homologous regions and others with repeat expansions. In particular, we will walk through an analysis of a trio of FXN cell lines

On-booth drinks reception

Join the Oxford Nanopore team and other nanopore users at Booth 400 to chat about current applications of our technology!

Date: Sunday, 25th May, 2025

Time: 15:30 – 16:30 CEST

Location: Booth 400, Exhibit Hall, Level 2

catering-eshg

Register